ETINZUE
DEAD

Serial Number

90729627

Owner

BRISTOL-MYERS SQUIBB COMPANY

Attorney

Marilyn F. Kelly

Filing Date

May 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ETINZUE Trademark

Serial Number: 90729627

ETINZUE is a trademark filed by BRISTOL-MYERS SQUIBB COMPANY on May 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

BRISTOL-MYERS SQUIBB COMPANY (4,806 trademarks)

NEW YORK, NY 10154

Entity Type: 03

Trademark Details

Filing Date

May 24, 2021

Registration Date

Not Registered

Published for Opposition

August 23, 2022

Goods & Services

Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 24, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 24, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 22, 2025 EXRA
SOU EXTENSION 5 GRANTED
Jul 21, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 21, 2025 AITU
SOU TEAS EXTENSION RECEIVED
Apr 7, 2025 EEXT
SOU EXTENSION 5 FILED
Apr 6, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 15, 2024 EXRA
SOU EXTENSION 4 GRANTED
Oct 15, 2024 EX4G
SOU EXTENSION 4 FILED
Oct 15, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 15, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 15, 2024 EXRA
SOU EXTENSION 3 GRANTED
Mar 14, 2024 EX3G
SOU EXTENSION 3 FILED
Mar 14, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 14, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2023 EXRA
SOU EXTENSION 2 GRANTED
Oct 3, 2023 EX2G
SOU EXTENSION 2 FILED
Oct 3, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 3, 2023 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 2, 2023 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 2, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 2, 2023 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 31, 2023 EXRA
SOU EXTENSION 1 GRANTED
Mar 29, 2023 EX1G
SOU EXTENSION 1 FILED
Mar 29, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 29, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 18, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 23, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 23, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 3, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 21, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 23, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 23, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 28, 2021 GNRN
NON-FINAL ACTION E-MAILED
Dec 28, 2021 GNRT
NON-FINAL ACTION WRITTEN
Dec 28, 2021 CNRT
ASSIGNED TO EXAMINER
Dec 27, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 19, 2021 NWOS
NEW APPLICATION ENTERED
May 27, 2021 NWAP